Skip to content
Search

Latest Stories

London pharmacist gets second FtP warning for anti-Semitic remarks made at 2017 rally

The General Pharmaceutical Council's Fitness-to-Practise (FtP) committee has reversed its earlier decision ruling that a London pharmacist's statement, attributing the Grenfell tragedy to "Zionist supporters of the Tory party," amounted to the propagation of anti-Semitic tropes.

In an initial 2020 hearing, the FtP committee found that a set of remarks delivered by Nazim Hussain Ali, Managing Partner of Chelsea Pharmacy Medical Clinic, through a megaphone to a crowd assembled at a Palestinian rights rally in central London in 2017 were deemed "grossly offensive," but not classified as anti-Semitic.


Ali admitted his comments were offensive, but he was cleared of accusations of antisemitism and received a first warning on November 5, 2020.

However, the High Court overturned this decision in June 2021 following an appeal by the Professional Standards Authority as the Judge found evidence of a "serious procedural or other irregularity" in the FtP committee's decision and instructed the GPhC to reopen the case.

Later, the GPhC concluded that the Grenfell events were not linked to Zionism, which involves the development and protection of the State of Israel. Therefore, using the term Zionism in this context would be perceived by a 'reasonable person' as an instance of the anti-Semitic trope.

In a recent hearing from August 29-31, FtP committee determined that two of Ali's statements, out of four submitted for consideration, were indeed anti-Semitic.

  • “Any Zionist, any Jew coming into your centre supporting Israel, any Jew coming into your centre who is a Zionist. Any Jew coming into your centre who is a member for the Board of Deputies, is not a Rabbi, he’s an imposter.”
  • “They are responsible for the murder of the people in Grenfell. The Zionist supporters of the Tory Party.”

The committee found that Ali's remarks constituted "serious misconduct" and a violation of a fundamental professional principle, which dictates that pharmacists must consistently exhibit appropriate behaviour.

'Adhere to pharmacy profession standards' 

In the repeat hearing, Ali received a formal warning, with no additional conditions on his license -- a parallel outcome to the initial 2020 FtP hearing. Taking into account factors including the spontaneous nature of his remarks, the committee deemed a suspension order to be disproportionate.

“The registrant, for all the reasons set out in the Committee’s decision, is hereby given a Warning that his future behaviour and comments that he makes must at all times avoid undermining the reputation of the profession, or the reputation of the regulator and must uphold the required standards of the pharmacy profession,” the FtP warning reads.

“He is reminded in particular that ‘behaving professionally is not limited to the working day, or face to face interactions. The privilege of being a pharmacist and the importance of maintaining confidence in the profession calls for appropriate behaviour at all time,” it added.

However, the Board of Deputies of British Jews strongly condemned the decision, with Amanda Bowman, one of its vice presidents, expressing 'deep concern' about the outcome.

“The Board of Deputies is steadfast in its work to combat hate speech and antisemitism in all parts of society including in the pharmaceutical profession,” Bowman said in a statement. “We believe that this case raises important questions about the standards and values upheld by the GPhC and its Fitness to Practise Committee.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less